Search for: "Mylan Pharmaceuticals, Inc"
Results 1 - 20
of 496
Sorted by Relevance
|
Sort by Date
9 Jan 2020, 8:25 pm
Mylan Pharmaceuticals Inc. is recalling certain batches of its Nizatidine Capsules, USP, over concerns they may contain a carcinogen. [read post]
5 Apr 2020, 9:57 pm
Mylan Pharmaceuticals Inc., the Federal Circuit reversed a decision by the U.S. [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending… [read post]
7 Dec 2023, 9:59 pm
Mylan Pharmaceuticals Inc., with the Court vacating and remanding the District Court's claim construction for failure to consider extrinsic evidence. [read post]
9 Nov 2021, 9:31 pm
Mylan Pharmaceuticals Inc. [read post]
9 Nov 2021, 9:31 pm
Mylan Pharmaceuticals Inc. [read post]
31 Jan 2017, 8:55 pm
§ 102(f), in Cumberland Pharmaceuticals Inc. v. [read post]
10 Jun 2009, 9:02 pm
Seeking approval to market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. [read post]
6 Sep 2016, 3:36 pm
The New York Attorney General is investigating whether leading EpiPen Manufacturer, Mylan Pharmaceuticals, violated New York antitrust laws by inserting anticompetitive terms into its EpiPen sales contracts with numerous local school systems. [read post]
8 Apr 2020, 9:59 pm
Mylan Pharmaceuticals Inc. [read post]
5 Oct 2022, 8:12 pm
Patent No. 7,326,708 were either anticipated or rendered obvious by the asserted prior art, in Mylan Pharmaceuticals Inc. v. [read post]
22 Jul 2018, 8:32 pm
Mylan Pharmaceuticals, affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
14 Feb 2019, 9:50 pm
RE38,551 challenged in inter partes review were not unpatentable for obviousness, in Mylan Pharmaceuticals Inc. v. [read post]
17 Dec 2008, 5:54 am
The challenges to the '777 patent had been initiated by Defendants-Appellants Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., and UDL Laboratories, Inc. [read post]
12 Dec 2011, 9:59 pm
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
8 Aug 2013, 9:59 pm
Mylan Pharmaceuticals Inc. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
18 Oct 2009, 5:42 pm
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...] [read post]
15 Aug 2022, 3:10 am
Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units/mL, 3 mL. [read post]
10 Nov 2020, 8:53 pm
Mylan... [read post]
